维普期刊资源整合服务平台（V6.5）

168篇 您的检索式：作者名="TUTT A"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Optical and visual impact of tear break-up in human eyes显示文摘	Bradley A Begley C	2000	Invest Ophthalmol Vis Sci2000，41，13：	1
2	Hallmarks of 'BRCAness' in sporadic cancers 显示文摘	Turner N Tutt A Ashworth A	2004	Nature Reviews Cancer2004，4，10：	1
3	Triple negative tumours: a critical review 显示文摘	Reis-Filho J S Tutt A N	2008	Histopathology2008，52，1：	1
4	Absence of Brea2 causes genome instability by chromosome breakage and loss associated with centrosome amphfication 显示文摘	Tutt A Gabriel A Bertwistle D	1999	Curt Biol1999，9，19：	1
5	Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-con- cept trlal显示文摘	Tutt A Robson M C arber JE	2010	Lancet2010，376，9737：	1
6	Therapeutic potential of PARP inhibitors for metastatic breast cancer显示文摘	Irshad S Ashworth A Tutt A		0，，：	1
7	Dissecting the heterogeneity of triple-negative breast cancer显示文摘	Metzger-Filho O Tutt A de Azambuja E	2012	J Clin Oncol2012，30，15：	1
8	Oral poly(ADP-ribose) polymer- ase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial 显示文摘	Tutt A Robson M Garber JE	2010	Lancet2010，376，9737：	1
9	Hallmarks of 'BRCAness' in sporadic cancers 显示文摘	Turner N Tutt A Ashworth A	2004	Nature Review Cancer2004，4，10：	1
10	Oral poly(ADP-ribose) poly- merase inhibitor olaparib in patients with BRCA1 or BRCA2 muta- tions and advanced breast cancer: a proof-of-concept trial 显示文摘	Tutt A Robson M Garber JE	2010	Lan- cet2010，376，9737：	1
11	Hallmarks of 'BRCAness' in sporadic cancers显示文摘	Turner N Tutt A Ashwonh A	2004	Nat Rev Cancer2004，4，：	1
12	Optical and visual impact of tear break-up in human eyes显示文摘	Tutt R Bradley A Begley C	2000	Invest Opbthalmol Vis Sei2000，41，13：	1
13	Oral poly(ADP-ri- bose) polymerase inhibitor olaparib in patients with BRCAI or BRCA2 mutations and advanced breast can- cer: a proof-of-concept trial显示文摘	Tutt A Robson M Garber JE	2010	Lancet2010，376，9737：	1
14	Optical limiting with C60 in polymethyl methacrylate 显示文摘	Kost A Tutt L	1993	Optics Letters1993，，18：	1
15	The relationship between the roles of BRCA genes in DNA repair and cancer predisposition显示文摘	Tutt A Ashworth A	2002	Trends Mol Med2002，8，12：	1
16	显示文摘	Tutt L Kost A	1992	Nature1992，356，：	1
17	Oral poly ( ADP-ribose ) poly- merase inhibitor olaparib in patients with BRCA1 or BRCA2 muta- tions and advanced breast cancer: a proof-of-concept trial 显示文摘	Tutt A Robson M Garber JE	2010	Lancet2010，376，9737：	1
18	Dissecting the heterogeneity of triple-negative breast cancer显示文摘	Metzger-Filho O Tutt A de Azambuja E	2012	J Clin Oncol2012，30，15：	1
19	Hallmarks of 'BRCAness' in sporadic cancers显示文摘	TURNER N TUTT A ASHWORTH A	2004	Nat Rev Cancer2004，4，10：	1
20	Dissec- ting the heterogeneity of triple-negative breast cancer显示文摘	Metzger-Filho O Tutt A de Azambuja E	2012	J Clin Oncol2012，30，15：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示